THE CASE FOR NA­TIONAL PHARMACARE

ZOOMER Magazine - - FRONT PAGE -

WITH FLU SEA­SON upon us, CARP’s di­rec­tor of com­mu­nity af­fairs An­thony Quinn met with the Regina chap­ter to lobby the Saskatchewan gov­ern­ment to cover the high-dose vac­cine. Quinn pointed out that, this year, On­tario will fund the new high-dose flu shot, de­vel­oped specif­i­cally for se­niors that is 24 per cent more ef­fec­tive than the reg­u­lar shot. Se­niors ac­count for 70 per cent of all flu-re­lated hos­pi­tal­iza­tions and 90 per cent of flu-re­lated deaths. With prov­inces deal­ing with health-care fund­ing is­sues, Quinn says the new flu vac­cine will pay for it­self, both in the preven­tion of ill­ness, death and in the re­duc­tion of hos­pi­tal­iza­tion costs. While the Na­tional Ad­vi­sory Com­mit­tee on Im­mu­niza­tion says there is “good ev­i­dence” that the high-dose flu vac­cine pro­vides bet­ter pro­tec­tion, many older peo­ple will forego the more ef­fec­tive shot un­less it’s cov­ered. Quinn con­grat­u­lated CARP’s Nova Sco­tia chap­ter, which suc­cess­fully lob­bied the gov­ern­ment to pro­vide the high­dose shots to long-term care res­i­dents.

CARP pres­i­dent Moses Znaimer re­ceiv­ing the high-dose flu shot from CARP Health 360 nurse, Michelle Colenutt, at the 2017 Toronto ZoomerShow

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.